Objectives

Examine the diagnostic tests available for AGHD and current recommendations
‍
Analyse real-world cases to understand the clinical benefit of macimorelin for HCPs and patients
‍
Review for mulary challenges with macimorelin and strategies to improve patient access

Meeting Agenda–In-person participants only

Time
Session
‍Facilitator/Speaker
Notes
17:30 – 18:00
Pre-event networking for in‑person participants
Jonathan Daly, Tor‑Sverre Johannesen and Dr. Robert Murray
Participants are allowed to enter the room 30 minutes before the event starts to network with their peers, Pharmanovia staff, and the meeting chair and speakers
‍
Food and beverage to be provided
18:00 – 18:10
(10 min)
Welcome and Introduction
Jonathan Daly and Dr. Robert Murray
Jonathan to open the meeting

Dr.Robert Murray to walk through agenda and introduce the speakers for the webinar
18:10 – 19:10
(10 Min)
Diagnostic landscape for AGHD
Dr. Gudmundur Johansson
Presentation(45 min)

Overview of the various tests used to diagnose AGHD, including his experience and recommendations

Q&A(15 min)
19:10 – 19:25
(15 min)
Break
Break for in-person participants and allows Pharmanovia/Node to set up for attendees joining through the virtual platform
‍
‍NOTE: can consider using this 15-minute break as the pre-meeting networking for virtual participants (i.e., a virtual waiting room where participants can chat before the webinar starts)